Conference Description
The Comparative Hematopoiesis GRC has a particular importance for the Veterinary Profession. The GRC committees are aware of this as well as Dr. Kaneko and myself. Aside from being a new GRC, it will be the first time in the 68 years since the conferences have been initiated that emphasis and participation of veterinarians doing research in academia and industry has been stressed. As you can see from the agenda, many of the speakers are veterinarians. However, the involvment of M.D.'s is very important and is to be noted. This will give a useful interplay between disciplines of the veterinary profession and human oriented research.
The goals of such diverse research may not always be the same - in terms of potential applications in human and veterinary medicine - but, it allows basic research issues to be discussed and brought to the forefront of the disciplines. This may be an on-going approach for some of the speakers and conferees present. It is all the more important since it can readily advance the "frontiers of science" for mutual benefits.
The success of this conference could readily lead the way to other Gordon Conferences which will involve some of the same interdisciplinary functions and goals, by stressing areas of Veterinary Research which may have been minimized or exempted in the past. With some of these goals in mind, I am sure that your role in this conference will be seen as one that is important and everyone will put their best foot forward to make it a very enlightening and successful conference.
Sunday, Aug.8, pm. | Introduction |
Discussion Leader:
Alan Rebar, DVM., PhD., Purdue Univ.
- Jon P.Kimball, PhD., R.W. Johnson Pharmaceutical Research Inst.
Preclinical assessment of new analytical methods and parameters for evaluating multispecies erythropoiesis
- Eugene Jackson, Jr., Abbott Diagnostics
The First Hematology Analyzer with Integrated Argon-ion Laser Flourescence Technology
- Padma K. Narayanan, DVM., PhD., Smith Kline Beecham Research
Bone Marrow Assessment in Mice by Flow Cytometry
Monday, Aug. 9, am. | Stem Cells - I |
Discussion Leader:
John Harvey, DVM., PhD., Univ. of Florida
- Janet Yamamoto, PhD., University of Florida
Immunological Assessment of BMT Cats: The Role of Stem Cell Factors in BMT Engraftment
- Janis Abkowitz; MD., Univ. of Washington
Feline Hematopoietic Stem Cells
- Paul J. Simmons, PhD., Matthew Roberts Labor., Adelaide, Australia
"Characterisation of Ovine Hematopoietic and Stromal Cell Precursors"
Monday, Aug. 9, pm. | Stem cells - II |
Discussion Leader:
Kenneth I. Weinberg, MD., Univ. of Southern California
- Beth L. Hill, PhD., Systemics Inc
Strategies for Efficient Hemopoietic Stem Cell Based Gene Therapy
- Peter Gasper, DVM., PhD., Univer. of Maryland
Intracellular Immunization in Cats: Hematopoietic Stem Cell Gene Therapy for Retrovirus Infections (Prophylaxis of fetal hematopoietic stem cells for FIV in cats)
Tuesday, Aug. 10, am. | Erythropoiesis - I |
Discussion Leader:
Linda Logan-Henfrey, DVM., PhD., ARS, U.S.D.A.
- Eugene Goldwasser, PhD., Univ. of Chicago
Erythropoietin Biogenesis
- H. Suliman, DVM., PhD., Duke Univ.
Analysis of EPO and EPO receptor gene expression in cattle during acute infection with Trypanosoma congolese
- James MacLeod, DVM, Cornell Univ.
Development and Therapeutic Considerations in the Use of Species-Specific Recombinant Erythropoietin Preparations for Companion Animals
Tuesday, Aug. 10, pm. | Erythropoiesis - II |
Discussion Leader:
Gary Kociba, DVM., PhD., Ohio State Univ.
- William Miller, PhD., Northwestern University
Oxygen Tension and pH Modulate Hematopoietic Progenitor Cell Proliferation and Differentiation
- Josef T. Prchal, M.D., University of Alabama at Birmingham
Molecular Interactions of Erythropoietin/Erythropoietin Receptor in "New World" Hystricomorph Rodents--Differ from those of Eutherian Mammals: Implications for Erythropoietin - Erythropoietin Receptor Interaction
Wednesday, Aug. 11, am. | Leukopoiesis - I |
Discussion Leader:
Thomas MacVittie, PhD., Univ. of Maryland
- Robert Donahue, DVM., PhD., Hematology Branch of NHLBI, Rockville, MD.
Transplantation of non-Human CD34+ cells Transduced with Enhanced Green Flourescent Protein-Expressing Lentiviral and Murine Stem cell Virus Vectors
- Fred Quimby, DVM, Cornell Univ.
Cytokines as Markers of Canine Lymphocytes Differentiation
- Russette Lyons, PhD., Genetic Therapy Inc.
Gene Therapy for the treatment and Prevention of Graft versus Host disease in Canines (MHC-haploidentical transplants)
Wednesday, Aug. 11, pm. | Leukopoiesis - II |
Discussion Leader:
Ian McNiece, PhD., Univ.Hospital, Univ. Colorado
- Peter Felsburg, VMD., PhD., Univ. of Pennsylvania
Canine X-linked SCID: A Model for Investigating the Requirement for the Common Gamma Chain In Human Lymphocyte Development and Function
- Thomas Schall, PhD. Chemocentryx, Inc.
Mouse/Monkey Models and Effects of Viruses on Gene changes in Cytokines and Receptors in Leukopoiesis
- Ellen Ziemer, MS., DVM., Lab Corp. of America
Murine Bone Marrow Transplantation: A Morphologic and Kinetic Analysis
Thursday, Aug. 12, am. | Thrombopoiesis - I |
Discussion Leader:
Bernard Feldman, DVM., Ph.D, Virginia-Maryland Regional College of Veterinary Medicine
- Ramesh Shivdasani, MD., PhD., Dana Farber Cancer Institute -Harvard Univ.
Molecular aspects of Megakaryocyte Differentiation
and Platelet Biogenesis (NF-E2 knockout mice used)
- Issac Cohen, PhD., Northwestern Univ.
Megakaryocytopoiesis in Three Hematopoietc Sources - Role of Stroma
- Paul Frenette, MD., Mount Sinai School of Medicine
Initial Interactions of Hematopoietic Progenitors and Platelets with the Endothelium using Murine Models (etc; intra-vital microscopy of platelet-endothelial interactions)
Thursday, Aug. 12, pm. | Thrombopoiesis - II |
Discussion Leader:
Douglas Weiss, DVM., PhD., Univ. of Minnesota
- Fern Tablin, DVM., PhD., Univ. of California, Davis
Megakaryocyte Demarcation Membranes: their isolation, biophysical and biochemical characterization and relationship to platelet plasma membrane
- John Hartwig, PhD., Peter Bent Brigham Hospital
A Specialized Cytoskeleton allows Platelets to both Circulate as Stable Discs and Remodel to Active Shapes